|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/14 | (2017.01) |
| A61K 47/44 | (2017.01) | ||
| A61K 9/107 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/66 | (2006.01) | ||
| A61K 31/569 | (2006.01) |
| (11) | Number of the document | 2934591 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13819021.0 |
| Date of filing the European patent application | 2013-12-19 | |
| (97) | Date of publication of the European application | 2015-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/077300 |
| Date | 2013-12-19 |
| (87) | Number | WO 2014/096139 |
| Date | 2014-06-26 |
| (30) | Number | Date | Country code |
| 12198529 | 2012-12-20 | EP |
| (72) |
HŲJGAARD, Bent, DK
|
| (73) |
Solural Pharma Aps,
Energivej 42, 2750 Ballerup,
DK
|
| (54) | SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE |
| SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE |